AVEO Pharmaceuticals Stock Price (NASDAQ:AVEO)

Add to My Stocks
$2.33 $0.07 (3.1%) AVEO stock closing price Aug 17, 2018 (Closing)
Prev Close* : $2.26
Market Cap:
$277.34M
Day Low: $2.15
52 Week Low: $1.86
Open: $2.29
Volume: -
Day High: $2.37
52 Week High: $4.24
Dividend:
0.00

AVEO Pharmaceuticals Stock Articles & Video

more news on AVEO stock

AVEO Pharmaceuticals News - From Partners

AVEO Stockcharts

View AVEO PE ratio, PS ratio stocks charts and compare with peers.
AVEO Chart
Note: Compare AVEO Pharmaceuticals stock price history with the index and industry peers.

AVEO Pharmaceuticals Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
45.06
PB ratio (
price to book ratio
)
-6.92

AVEO Pharmaceuticals Returns

ROE
(return on equity)
-

AVEO Pharmaceuticals Financial Ratios

Asset Turnover
0.09
Receivables Turnover
0.88
Debt to Equity
-
Dividend Yield
0%

AVEO Industry Peers

Company Price Change (%)
Nicox (NICXF)8.930 (0%)
Sequenom (SQNM)2.390 (0%)
Atara Bio (ATRA)35.90.85 (2.43%)
Incyte (INCY)68.80.95 (1.4%)
Bristol-myers Squibb (BMY)60.890.22 (0.36%)
Amgen (AMGN)197.420.98 (0.5%)
Incyte (INCY)68.80.95 (1.4%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
MiMedx (MDXG)3.890.36 (10.2%)
Organovo (ONVO)1.260.1 (8.62%)
ZIOPHARM Oncology (ZIOP)2.860.17 (6.32%)
Retrophin (RTRX)28.51.45 (5.36%)
Compugen (CGEN)3.50.15 (4.48%)
Ligand Pharma (LGND)247.988.32 (3.47%)
AVEO Pharmaceuticals (AVEO)2.330.07 (3.1%)
Top gainers from Medical-Biomed-Genetics industry
* As of Aug 18, 2018
CompanyPriceChange (%)
ELOXX PHARMACT (ELOX)11.951.83 (13.28%)
Xoma (XOMA)15.821.59 (9.13%)
IOVANCE BIOTHPT (IOVA)14.90.95 (5.99%)
Fortress Biotech (FBIO)1.910.12 (5.91%)
MannKind (MNKD)1.070.06 (5.31%)
Idera Pharma (IDRA)8.80.47 (5.07%)
Five Prime Therapeutics (FPRX)13.180.57 (4.15%)
Top losers from Medical-Biomed-Genetics industry
* As of Aug 18, 2018

AVEO Pharmaceuticals, Inc. Stock News - Partner Headlines

AVEO Pharmaceuticals Financial Statements

income statement20172016201520142013
Net Sales or Revenues7.57M2.51M19.02M18.12M1.29M
Net Income-65.02M-26.88M-15M-52.73M-107.02M
Total Operating Expense36.38M31.9M31.44M68.56M105.18M
View AVEO Pharmaceuticals income statement
balance sheet20172016201520142013
Total Assets50.19M27.28M40.54M70.66M146.34M
Total Liabilities90.96M29.2M23.31M50.05M76.4M
Shareholders Equity-40.76M-1.92M17.22M20.6M69.93M
View AVEO Pharmaceuticals balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities8.37M-0.93M-15.1M-18.57M13.43M
Net Cash from (used by) Operating Activities-19.16M-31.06M-18.23M-54.24M-84.4M
Increase (Decrease) in Prop Plant And Equipment--0.01M1.21M-12.75M-3.66M
View AVEO Pharmaceuticals cash flow statement

AVEO Pharmaceuticals Stock Message Board

AVEO Pharmaceuticals stock gained 3.1%, and the last close price as of Aug 17, 2018 is $2.33 for AVEO stock. AVEO Pharmaceuticals market capitalization is $277.34M and it represents the total market value of AVEO stock. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing AVEO Pharmaceuticals stock analysis.

Demand for a stock decides its stock market price. For example, if more investors want to buy AVEO stock than sell it, then AVEO Pharmaceuticals stock price goes up. Conversely, if more investors wanted to sell AVEO stock than buy it, there would be greater supply than demand, and the stock price would fall. The volume of shares traded stood at 4,502,243 on the last trading day, as is evident from AVEO Pharmaceuticals stock chart, and AVEO stock quote data. A dividend is a cash payment made from a company's earnings and is distributed among shareholders. AVEO Pharmaceuticals does not pay dividends. To check the historical stock price movement, all time high, and all time low of AVEO, view AVEO Pharmaceuticals stock price history.